Y Hu, Z Zhang, A Adiham, H Li, J Gu… - International Journal of …, 2025 - mdpi.com
Hepatic fibrosis (HF) is an important pathological state in the progression of chronic liver disease to end-stage liver disease and is usually triggered by alcohol, nonalcoholic fatty …
Y Zheng, H Ying, J Shi, L Li, Y Zhao - Nutrients, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) manifests as a persistent liver ailment marked by the excessive buildup of lipids within the hepatic organ accompanied by inflammatory …
Glutamine availability may be reduced in chronic diseases, such as type 2 diabetes mellitus (T2DM)-induced by obesity. Herein, the antioxidant, anti-inflammatory and lipid metabolism …
L Ma, J Zhu, X Kong, L Chen, J Du, L Yang… - Clinical …, 2024 - Taylor & Francis
Introduction Although valproic acid is generally well tolerated, hepatotoxicity is a common side effect in patients receiving long-term treatment. However, the mechanisms underlying …
Y Liu, W Yin - Hepatology Communications, 2025 - journals.lww.com
Abstract Cluster of differentiation 36 (CD36) is a transmembrane glycoprotein with the ability to bind to multiple ligands and perform diverse functions. Through the recognition of long …
SY Park, JE Kim, HM Kang, KH Park, BI Je, KW Lee… - Foods, 2024 - mdpi.com
In recent years, there has been increasing interest in exploring the potential therapeutic advantages of Citrullus mucosospermus extracts (CME) for nonalcoholic steatohepatitis …
T Wu, J Kessler, H Zhao, Y Zhao - … Acta Part A: Molecular and Biomolecular …, 2024 - Elsevier
Phosphorylated peptides are instrumental in studying protein phosphorylation events. In the present study, Raman optical activity (ROA) is employed to elucidate the structure of a …
S Zhang, S Zheng, Y Li, J Yang, X Mao… - … of Biochemical and …, 2024 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is an alarming ailment that leads to severe liver damage and increases the risk of serious health conditions. The prevalence of NAFLD due …